Deal Risk

How do I validate quality of earnings and spot aggressive accounting before signing?

USD 49 single Risk Briefing|Delivered within 4 hours|Reference material, not advice
Configure your report

What this risk is, and why it matters

Quality of earnings asks whether a target's reported profit is real, repeatable and cash-backed, or has been engineered ahead of a sale through aggressive recognition, cost capitalisation or working-capital timing. For a senior executive, this is the number that drives the price, because the valuation multiple multiplies any distortion. An earnings base that quietly normalises downward after close converts an attractive multiple into a loss the board will struggle to explain.

Legal and regulatory framework

Earnings quality is governed by the applicable accounting framework, typically IFRS or US GAAP, with revenue standards such as IFRS 15 and ASC 606 central to recognition disputes. Audited accounts give comfort but not immunity, and auditor regulators in many markets have intensified scrutiny of revenue and impairment judgements. Where misstatement is deliberate, securities-disclosure and fraud regimes can apply, raising the stakes well beyond a price adjustment.

Typical scenarios and impact

Typical scenarios run from clean normalisation adjustments that shift EBITDA by a few percentage points, to material restatements where aggressive recognition unwinds and the implied valuation collapses. Because price is a multiple of earnings, a modest overstatement can translate into a disproportionately large overpayment. Where manipulation is later established, consequences extend to indemnity claims, warranty litigation and, for listed buyers, market and reputational fallout.

Mitigation framework and when to engage an expert

Commission an independent quality-of-earnings analysis that rebuilds normalised EBITDA, tests revenue cut-off, and reconciles profit to cash. Tie agreed adjustments to the price and to specific warranties and indemnities, and use locked-box or completion-accounts mechanics deliberately. Engage forensic accountants where the figures look managed and deal counsel to convert findings into contractual protection. Treat unexplained earnings quality questions as a reason to pause, not to proceed faster.

Read the report. Talk to an expert.

This research is a starting point, not a verdict.

A Risk Briefing in the Deal Risk Domain tells you what the risk looks like, what the law says, and what indicators to watch. It does not replace a senior adviser who knows your jurisdiction, your industry, and your specific exposure. Senior advisors who have published on this exact question for your country appear at the bottom of this page once you have configured for a country. Download a Report for free; contact details live inside each PDF.

Configure for your country and industry

Pick a jurisdiction and an industry. Receive the report within 4 hours.

Country, optional state or region, and optional industry. Single Risk Briefing USD 49. Or buy the entire Domain Bundle (40 Risk Briefings) for USD 1,372 Save USD 588 (30%).

For Expert-Partners

Publish on this exact question

Buyers researching this risk in their country see your Report on this page. A Single Seat is USD 495 a year, up to five firms per page, and a Pro Seat is USD 1,485 for the larger card at the top. All 40 Deal questions in one country cost USD 13,860/yr (save usd 5,940 (30%)). Registration is free and shows which of them are open before you choose.

Reference material for informed readers, not professional advice. Reports are produced against current, verifiable sources; material claims are referenced. Always consult a qualified adviser before acting on the contents of a report. Browse all Intelligence Reports.